Title: An integrated target validation and drug discovery platform for the identification of novel agents targeting genome stability for the treatment of cancer

Wellcome Trust

Principal Investigator

Ruthardt, Martin

Project Details
Net value award figure for Cardiff University: £61,912.00
Start date: 01/09/2019
End date: 28/02/2021

Last updated on 2020-06-08 at 06:01